AI & Machine Learning

Founder Chuck Cohn pours millions more into his ed-tech firm, a bold move that signals deep confidence despite a slumping stock and cautious analysts.

With a hot obesity pipeline and a key neurology asset, Nxera Pharma's J.P. Morgan talk is a crucial test of its plan for global leadership.

With a $257M war chest and a veteran team, BlossomHill will showcase its innovative pipeline for lung cancer and leukemia at the pivotal JPM conference.

William Healey, a 25-year veteran, takes the helm as IAAO's 2026 President, guiding the future of global property valuation amid technological change.

AUKEY unveils a 200W GaN charging hub with retractable cables and 25W Qi2, leading a new lineup designed to declutter the modern professional's desk.

With stunning clinical data for its miv-cel therapy, Kyverna is set to outline a new era for autoimmune treatment at the J.P. Morgan conference.

A new partnership aims to accelerate driver safety tech in next-gen vehicles, merging AI monitoring with a fortress-like operating system.

With 35 years at the company, new CEO John Baylouny plans to accelerate R&D and expand into new markets, building on a period of strong growth.

QuinStreet's major acquisition of HomeBuddy aims to reshape the digital home services market by combining scale with exclusive, high-intent contractor leads.

Dnsys scores three CES 2026 Innovation Awards for its Z1 exoskeleton, merging advanced human augmentation with gaming culture for the consumer market.

Routeware appoints proven tech leaders Jeremy Collins and Ray Greer to drive its next growth phase, focusing on platform modernization and market leadership.

A new solution promises to bridge the gap between social media ads and retail sales, turning fuzzy awareness campaigns into measurable performance drivers.

A new partnership between etherWhere and AsiaRF promises ultra-low power, high-precision location tracking for everything from police cameras to Wi-Fi 7.

A tiny implant stimulating the vagus nerve offers new hope for severe RA. A landmark study now validates this bioelectric therapy for patients out of options.

Off The Hook's new luxury division leverages AI and an integrated model to secure ~$100M in listings and close 22 deals in its explosive first quarter.

A new integration brings Ceres AI's insights directly into the John Deere Operations Center, tackling data fragmentation for growers and insurers alike.

A new therapy claims to reverse cellular aging to cure disease, but its patient-funded trial model sparks a debate on equity and medical ethics.

A new tech alliance aims to replace manual cementing with standardized, automated systems for safer, more reliable wells across the entire asset lifecycle.

With deep institutional and private sector tech experience, new CEO Andrew Bercich is tasked with guiding the U.S. workforce system through a pivotal era.

Amid a capacity crisis, a new model blending AI with human oversight gains traction, promising efficiency without sacrificing the crucial element of patient care.